STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma (VENICE)

New World Medical

Status: Enrolling

Conditions: Open Angle Glaucoma

Treatments: Device: Streamline Surgical System; Device: iStent Inject W

Study type: Interventional

Funder types: Industry

Identifiers

NCT05280366

DF6-CL-21-02

Details and patient eligibility

About

A study of the Streamline Surgical System versus competitor

Enrollment: 150 estimated patients

Sex: All

Ages: 22+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Diagnosis of Mild to Moderate Primary Open Angle Glaucomma

Exclusion criteria

• Other types of glaucoma including but not limited to: Normal tension glaucoma, pseudoexfoliative glaucoma, narrow angle glaucoma, traumatic, congenital, malignant, uveitic or neovascular glaucoma. Ocular hypertension.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

150 participants in 2 patient groups

Streamline Surgical System

Other group

Description:

Streamline Surgical System procedure administered

Treatment:

Device: Streamline Surgical System

iStent Inject W

Active Comparator group

Description:

iStent Inject W implanted

Treatment:

Device: iStent Inject W